BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nuvilex Growing Medical Marijuana Sciences To Lead Marijuana Research Industry


1/10/2014 9:09:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, NY--(Marketwired - January 09, 2014) - There aren't too many biotechnology companies in the marijuana space, but there's one that aims to be the leader among those in the industry. Nuvilex, Inc. (OTCQB: NVLX), through its wholly-owned subsidiary Medical Marijuana Sciences, is building a company that should compete with anyone in the sector. They're doing so in much the same way many winning sports franchises have found success -- sign the most talented free agents in the business.

Late last year, Dr. Mark Rabe, a well-known figure in the medical marijuana industry, was named as Chairman of the Scientific Advisory Board (SAB) for Medical Marijuana Sciences (MMS). In a recent statement by the company, Dr. Rabe issued a Charter with both the mission and a list of goals and objectives for the SAB.

Dr. Rabe vowed to recruit members to the SAB with stellar credentials, and this week the first of those recruits was named. Richard M. Hyslop, Ph.D. agreed to join Dr. Rabe on the SAB of MMS. Dr. Hyslop is a Professor of Chemistry and Biochemistry at the University of Northern Colorado.

With his expertise in anti-cancer drug design, the metabolism of anti-cancer drugs and studies of enzymes and enzyme-catalyzed reactions in biological tissues, Dr. Rabe expects that Dr. Hyslop will be an asset to the future success of MMS. Another advantage Dr. Hyslop brings to the table is that he's located in Colorado, a state that has legalized medical marijuana.

As the recruiting continues at MMS, Dr. Rabe is sure to only strengthen the company with a diverse team that can meet the goals he's set for Medical Marijuana Sciences including, developing treatments, which employ constituents of Cannabis together with the Cell-in-a-Box™ cellulose-based live-cell encapsulation technology, for some of the deadliest forms of cancer.

Nuvilex and MMS COO Dr. Gerald Crabtree said, "We believe that when the roster of SAB members is filled, the SAB will play a major role in fulfilling the goals and objectives of Medical Marijuana Sciences."

About Stock Market Media Group

SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.


Contact:
Stock Market Media Group
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Nuvilex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES